Does Urogen Pharma (URGN) Have the Potential to Rally 171.05% as Wall Street Analysts Expect?

Shares of Urogen Pharma (URGN) have gained 5.4% over the past four weeks to close the last trading session at $15.82, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $42.88 indicates a potential upside of 171.1%. The average comprises four short-term price targets ranging from a low of $18 to a high of $60, with a standard deviation of $18.56. While the lowest estimate indicates ...